You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cisplatin

Showing 26 - 50 of 1,923
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Rochester (Cisplatin)

Recruiting
  • Prostate Cancer
  • Cisplatin
  • Rochester, New York
    Wilmot Cancer Institute
Jun 7, 2022

Head and Neck Squamous Cell Carcinoma Trial in Pittsburgh (Pembrolizumab, Cisplatin, IMRT)

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 15, 2022

Nasopharyngeal Carcinoma, Recurrent or Metastatic Trial in Beijing (KL-A167, Gemcitabine, Cisplatin)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Recurrent or Metastatic
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Mar 23, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Strasbourg (Split Cisplatin, Cisplatin, Radiotherapy)

Completed
  • Squamous Cell Carcinoma of the Head and Neck
  • Split Cisplatin
  • +2 more
  • Strasbourg, France
    Centre Paul Strauss
Mar 10, 2022

Head Neck Cancer Trial in London, Wales (Olaparib, Cisplatin, IMRT)

Active, not recruiting
  • Head and Neck Cancer
  • London, United Kingdom
  • +2 more
Nov 1, 2022

Triple Negative Breast Cancer Trial in Shanghai (Gemcitabine, Cisplatin)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Shanghai, Shanghai, China
    Cancer Hospital/ Institute, Fudan University
Jul 19, 2022

Urothelial Carcinoma Bladder, PD-1 Inhibitor Trial in Shanghai (Tislelizumab, Gemcitabine, Cisplatin)

Recruiting
  • Urothelial Carcinoma Bladder
  • PD-1 Inhibitor
  • Shanghai, Shanghai, China
    Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
Aug 15, 2022

Extensive-stage Small-cell Lung Cancer Trial in China (serplulimab, Cisplatin, Carboplatin)

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Shantou, Guangdong, China
  • +6 more
Mar 1, 2023

Head and Neck Squamous Cell Carcinoma, Locally Advanced Operable Trial in Guangzhou (Cadonilimab, Docetaxel, Cisplatin)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Locally Advanced Operable
  • Guangzhou, Guangdong, China
  • +1 more
Sep 4, 2023

Penile Cancer Trial in Guangzhou (Albumin-Bound Paclitaxel, Ifosfamide, Cisplatin)

Completed
  • Penile Cancer
  • Albumin-Bound Paclitaxel
  • +4 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jun 8, 2022

Advanced Urothelial Carcinoma Trial in Bern (Magrolimab, Cisplatin, Gemcitabine)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Bern, Switzerland
    University Hospital Insel
Feb 20, 2023

Lung Cancer Trial in Houston (AMG 510, Cisplatin, Carboplatin)

Recruiting
  • Lung Cancer
  • AMG 510
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2022

Bile Duct Cancer, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable Trial in Boston (Gemcitabine, Cisplatin, Durvalumab)

Not yet recruiting
  • Bile Duct Cancer
  • +4 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 23, 2023

Gastric Adenocarcinoma Trial (Pembrolizumab, Cisplatin, 5-FU)

Completed
Has Results
  • Gastric Adenocarcinoma
  • Pembrolizumab
  • +4 more
  • (no location specified)
Aug 18, 2022

Intrahepatic Cholangiocarcinoma Trial (procedure, drug, biological)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Biopsy
  • +7 more
  • (no location specified)
Sep 21, 2023

Mesothelioma Trial in Houston (Pemetrexed, Cisplatin)

Terminated
  • Mesothelioma
  • Houston, Texas
    Baylor St Lukes
Mar 15, 2022

Biliary Tract Cancer, Cholangiocarcinoma Trial in Italy (Gemcitabine, Nab paclitaxel, Cisplatin)

Not yet recruiting
  • Biliary Tract Cancer
  • Cholangiocarcinoma
  • Ancona, Italy
  • +18 more
Sep 16, 2023

Hepatocellular Carcinoma Trial in Hong Kong (Cisplatin)

Recruiting
  • Hepatocellular Carcinoma
  • Cisplatin
  • Hong Kong, Hong Kong
    Department of Imaging and Interventional Radiology, Prince of Wa
Mar 10, 2022

Nasopharyngeal Carcinoma Trial in Guangzhou (QL1706, Carrelizumab, Gemcitabine)

Recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangzhou, China
    Sun Yat-sen University Cancer Center
Oct 21, 2022

Advanced Solid Tumors Trial in United States (ABBV-706, Cisplatin, Budigalimab)

Recruiting
  • Advanced Solid Tumors
  • Grand Rapids, Michigan
  • +3 more
Dec 13, 2022

Carcinoma, Small Cell Lung Trial in China (Atezolizumab, Cisplatin, Carboplatin)

Active, not recruiting
  • Carcinoma, Small Cell Lung
  • Beijing City, China
  • +7 more
Nov 24, 2022

Triple Negative Breast Cancer Trial in Shanghai (Cisplatin, Nab-paclitaxel, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Cisplatin
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 18, 2022

Gestational Trophoblastic Tumors Trial in Hangzhou (Etoposide, actinomycin D, methotrexate)

Recruiting
  • Gestational Trophoblastic Neoplasms
  • Hangzhou, Zhejiang, China
    Weiguo Lv
Jun 2, 2022

Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitors Trial (Cadonilimab, Gemcitabine, Cisplatin)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Immune Checkpoint Inhibitors
  • (no location specified)
Jun 1, 2023

Non-Squamous NSCLC Trial in Shanghai (Sintilimab, IBI305, Pemetrexed)

Recruiting
  • Non-Squamous Non-Small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Sep 22, 2022